2005N-0345 Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product
FDA Comment Number : EC1102
Submitter : Dr. JoshuA Underhill Date & Time: 10/27/2005 12:10:06
Organization : Southwestern Medical Clinic, PC
Category : Health Professional
Issue Areas/Comments
I am opposed to the sale of "morning after" dosing of oral contraceptives, marketed as a way to avoid pregnancy and available without any discussion with a health-care provider. This will almost certainly lead to a more casual regard for unprotected, extramarital sexual intercourse and hence increase the incidence and risk of sexually transmitted diseases. This approach also popularizes the casual disregard for what may be happening inside a woman's body after sexual intercourse - namely, the creation of a new human life. I hope that the FDA will completely reconsider its stance on the marketing of this medication over the counter without requiring untrained individuals to consult with a trained health- care provider.